![Igor Smolenov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Igor Smolenov currently works at Arcturus Therapeutics Holdings, Inc., as Chief Development Officer from 2023.
Dr. Smolenov also formerly worked at Clover Pharmaceuticals Corp., as Executive Vice President, Moderna, Inc., as Head-Clinical Development, and Seqirus, Inc., as Head-Therapeutic Area.
Dr. Smolenov received his doctorate degree from Volgograd State Medical University.
| Sociétés | Poste | Début |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Corporate Officer/Principal | 01/04/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Directeur Technique/Scientifique/R&D | - |
Seqirus, Inc.
 Seqirus, Inc. BiotechnologyHealth Technology Develops and manufactures vaccines & pharmaceuticals | Corporate Officer/Principal | - |
Clover Pharmaceuticals Corp.
 Clover Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Clover Pharmaceuticals Corp.
Clover Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seqirus, Inc.
Seqirus, Inc. BiotechnologyHealth Technology Develops and manufactures vaccines & pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
